Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Novacyt
  6. News
  7. Press Releases
    ALNOV   FR0010397232

NOVACYT

(ALNOV)
  Report
Real-time Euronext Paris  -  09:17 2022-10-04 am EDT
0.8556 EUR   +5.63%
10/03Novacyt : Contrat de liquidité
PU
10/03Novacyt : Liquidity Agreement
PU
09/29Transcript : Novacyt S.A., H1 2022 Earnings Call, Sep 29, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société NOVACYT
10/03Novacyt : Contrat de liquidité
PU
10/03Novacyt : Liquidity Agreement
PU
09/29Novacyt : Investor Presentation September 2022
PU
07/21Novacyt : Results of Annual General Meeting
PU
07/21Novacyt : AGM Investor Presentation
PU
07/15Novacyt - Approval of exsig COVID-19 Direct test in the UK under CTDA legislation
AQ
06/19Novacyt : Convening notice for 21st June 2022
PU
06/19Novacyt : Proxy voting form for 21st June 2022
PU
06/01Novacyt S.a. (“novacyt”, : Publication of Annual Report and AGM voting
BU
05/31Novacyt : Text of the resolutions
PU
04/28Novacyt : 2021 Management Report
PU
04/28Novacyt S.a. ("novacyt", The "compan : Full year 2021 results and update on growth strateg..
BU
04/20Novacyt : Notice of Full Year 2021 Results and Investor Presentation
PU
02/04Novacyt : Long Term Incentive Plan 2022 Performance Share Awards
PU
2021Novacyt : Results of Annual General Meeting
PU
2021Novacyt : 2021 agm
PU
2021Novacyt : Convening notice for 18th October 2021
PU
2021Novacyt : R&D update
PU
2021Novacyt : Notice of AGM
PU
2021Novacyt : Notice of rescheduled AGM
PU
2021Novacyt : 2021 agm
PU
2021Novacyt : Interim Accounts June 2021
PU
2021Novacyt : Rapport D'Activitie Semestriel 2021
PU
2021Novacyt : Half year 2021 results
PU
2021Novacyt : Proposed accounting treatment of ongoing DHSC dispute in 2021 interim results
PU
2021Novacyt : AGM voting
PU
2021Novacyt : Company's activity during FY20
PU
2021Novacyt : 2021 half year revenues
PU
2021Novacyt : Half Year Update
PU
2021Novacyt : Notice of investor meeting
PU
2021Novacyt : David Allmond announced as CEO following decision by Graham Mullis to retire
PU
2021Novacyt : Expansion of PathFlow® COVID-19 lateral flow test portfolio
PU
2021Novacyt : Rapport annuel et comptes Novacyt pour l'exercice clos en décembre 2020
PU
2021Novacyt : 2020 Management Report
PU
2021Novacyt : 2020 Group Consolidated Accounts
PU
2021Novacyt : Full year 2020 results and update on growth strategy
PU
2021Novacyt : Launch of two new PCR COVID-19 assays
PU
2021Novacyt : Launch of VersaLab™ Portable
PU
2021Novacyt S.a. ("novacyt", The "compan : Launch of VersaLab™ Portable
BU
2021Novacyt : Government and Covid test supplier Novacyt row over £150m PCR contract
AQ
2021Novacyt : DHSC Dispute Update
PU
2021Novacyt S.a. ("novacyt", The "compan : DHSC Dispute Update
BU
2021Novacyt S.a. ("novacyt", The "compan : Inclusion of SNPsig® SARS-CoV-2 PCR Genotyping Port..
BU
2021Novacyt : to support UNICEF with donation of one million COVID-19 tests
BU
2021Novacyt : R&D and UK operational update
PU
2021Novacyt : Update on Notice of 2020 Full Year Results
PU
2021Novacyt S.a. ("novacyt", The "compan : Launch of CE-Mark test to detect multiple COVID-19 ..
BU
2021Novacyt S.a. ("novacyt", The "compan : Launch of Mobile Processing Laboratories to Detect ..
BU
2021Novacyt S.a. :  Research and Development Update
BU
2021Novacyt S.a. :  Launch of PCR Genotyping Assay Portfolio to Detect COVID-19 Variants
BU
2021Novacyt S.a. : Full Year 2020 Trading Update
BU
2021Novacyt S.a. :  Executive Management and Proposed Board Changes
BU
2021Novacyt : Information mensuelle sur le contrat de liquidité et sur le nombre total de droi..
PU
2020Novacyt S.a. ("novacyt", The "compan : COVID-19 Diagnostic Tests Remain Able to Detect All..
BU
2020Novacyt : S.A. ("Novacyt :", the "Company" or the "Group") Development of Three Tests for ..
BU
2020Novacyt S.a. : ("Novacyt", the "Company" or the “Group”) R&D Update
BU
2020Novacyt S.a. : Acquisition of IT-IS International Ltd
BU
2020Novacyt : Results of annual general meeting
PU
2020Novacyt S.a. :  New Contract With UK DHSC for Instrument Platforms and COVID-19 Testing Ki..
BU
2020Novacyt : S.A. ("Novacyt :" or the "Company") Launch of COVID-19 Antibody Test
BU
2020Novacyt : Interim Accounts June 2020
PU
2020Novacyt : Rapport D'Activitie Semestriel 2020
PU
2020Novacyt S.a. ("novacyt", The "compan : Half Year 2020 Results
BU
2020Novacyt : Special Board report on resolutions
PU
2020Novacyt : Articles of Association
PU
2020Novacyt : Form to request documents
PU
2020Novacyt : The Board special report for EGM
PU
2020Novacyt : Company's activity during FY19
PU
2020Novacyt S.a. ("novacyt", The "compan : Launch of Two Gene COVID-19 Test
BU
2020Novacyt S.a. :  Launch of Respiratory Test Panel
BU
2020Novacyt : Avis de convocation à l'Assemblée générale des actionnaires
PU
2020Novacyt S.a. ("novacyt", The "compan : R&D Update
BU
2020Novacyt S.a. ("novacyt", The "compan : 2,000 Patient Clinical Trial Using Novacyt's Near-P..
BU
2020Novacyt S.a. ("novacyt", The "compan : Half-Year Trading Update
BU
2020Novacyt : AGM results July 2019
PU
1  2  3Next
Upcoming event on NOVACYT